BriaCell receives FDA clearance for breast cancer immunotherapy trial
Go back to BriaCell receives FDA clearance for breast cancer immunotherapy trial| (NASDAQ: BCTX) | Delayed: 3.01 +0.11 (3.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.90 | 52 Week High | $ | |||
| Open | $2.91 | 52 Week Low | $ | |||
| Day High | $3.09 | P/E | N/A | |||
| Day Low | $2.91 | EPS | $ | |||
| Volume | 72,488 | |||||
